Hillsdale Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,934
| Closed | -$1M | – | 611 |
|
|
2024
Q1 | $1M | Sell |
1,934
-390
| -17% | -$194K | 0.08% | 208 |
|
|
2023
Q4 | $1.1M | Hold |
2,324
| – | – | 0.09% | 208 |
|
|
2023
Q3 | $1.01M | Buy |
2,324
+740
| +47% | +$336K | 0.09% | 194 |
|
|
2023
Q2 | $704K | Buy |
1,584
+80
| +5% | +$36.9K | 0.06% | 198 |
|
|
2023
Q1 | $692K | Sell |
1,504
-10
| -0.7% | -$4.76K | 0.06% | 240 |
|
|
2022
Q4 | $777K | Sell |
1,514
-80
| -5% | -$40.6K | 0.07% | 208 |
|
|
2022
Q3 | $724K | Buy |
1,594
+6
| +0.4% | +$2.87K | 0.07% | 229 |
|
|
2022
Q2 | $766K | Buy |
1,588
+128
| +9% | +$63.3K | 0.06% | 228 |
|
|
2022
Q1 | $717K | Sell |
1,460
-100
| -6% | -$45.7K | 0.05% | 303 |
|
|
2021
Q4 | $723K | Hold |
1,560
| – | – | 0.05% | 308 |
|
|
2021
Q3 | $581K | Buy |
+1,560
| New | +$593K | 0.04% | 369 |
|
|
2020
Q4 | – | Sell |
-1,357
| Closed | -$364K | – | 611 |
|
|
2020
Q3 | $364K | Sell |
1,357
-120
| -8% | -$32.3K | 0.04% | 375 |
|
|
2020
Q2 | $389K | Buy |
+1,477
| New | +$394K | 0.04% | 372 |
|
|
2019
Q2 | – | Sell |
-25
| Closed | -$7K | – | 617 |
|
|
2019
Q1 | $7K | Buy |
+25
| New | +$7.23K | ﹤0.01% | 507 |
|
|
2018
Q4 | – | Sell |
-30
| Closed | -$8K | – | 598 |
|
|
2018
Q3 | $8K | Hold |
30
| – | – | ﹤0.01% | 367 |
|
|
2018
Q2 | $7K | Sell |
30
-10
| -25% | -$2.32K | ﹤0.01% | 386 |
|
|
2018
Q1 | $9K | Hold |
40
| – | – | ﹤0.01% | 346 |
|
|
2017
Q4 | $9K | Sell |
40
-2,000
| -98% | -$426K | ﹤0.01% | 356 |
|
|
2017
Q3 | $388K | Buy |
2,040
+300
| +17% | +$57.1K | 0.07% | 222 |
|
|
2017
Q2 | $328K | Buy |
1,740
+1,680
| +2,800% | +$302K | 0.06% | 229 |
|
|
2017
Q1 | $10K | Hold |
60
| – | – | ﹤0.01% | 348 |
|
|
2016
Q4 | $9K | Hold |
60
| – | – | ﹤0.01% | 356 |
|
|
2016
Q3 | $8K | Hold |
60
| – | – | ﹤0.01% | 393 |
|
|
2016
Q2 | $8K | Hold |
60
| – | – | ﹤0.01% | 407 |
|
|
2016
Q1 | $8K | Sell |
60
-10
| -14% | -$1.34K | ﹤0.01% | 389 |
|
|
2015
Q4 | $10K | Sell |
70
-2,700
| -97% | -$372K | ﹤0.01% | 382 |
|
|
2015
Q3 | $388K | Hold |
2,770
| – | – | 0.13% | 143 |
|
|
2015
Q2 | $455K | Buy |
+2,770
| New | +$443K | 0.14% | 133 |
|
|
2013
Q4 | – | Sell |
-3,600
| Closed | -$301K | – | 548 |
|
|
2013
Q3 | $301K | Hold |
3,600
| – | – | 0.09% | 192 |
|
|
2013
Q2 | $295K | Buy |
+3,600
| New | +$269K | 0.1% | 183 |
|
Other funds holding ELV
Hillsdale Investment Management's ELV Position: Q2 2024 in Review
Hillsdale Investment Management sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 1,934 shares — an estimated $1M sold.
Hillsdale Investment Management first reported a position in ELV in Q2 2013 and held it in 30 quarters. The position peaked at $1.1M in Q4 2023. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.
- Hillsdale Investment Management reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
- Hillsdale Investment Management sold 1,934 Elevance Health shares in Q2 2024, an estimated $1M.
- Hillsdale Investment Management first reported a position in Elevance Health in Q2 2013 and held it in 30 quarters.
- Hillsdale Investment Management's Elevance Health position peaked at $1.1M in Q4 2023.
- 1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.
Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.